We are on a mission to protect the world from cardiovascular disease
Verve at a Glance
Heart is at the center of everything we do
- Cardiovascular disease (CVD) is the leading cause of death, directly impacting hundreds of millions of people worldwide. Verve is on a mission to protect the world from CVD.
- Leveraging advances in the understanding of human genetics and gene editing, Verve is seeking to change the treatment paradigm for CVD.
- Verve is advancing a pipeline of single-course in vivo gene editing programs intended to safely turn off genes in the liver that contribute to CVD risk.
Verve was purpose-built to disrupt today’s chronic care model for CVD, with a team of experts in cardiovascular medicine, genetics, gene editing, delivery technologies and drug development.
Meet our teamOur lead program, VERVE-101, is being evaluated in the Phase 1b heart-1 clinical trial
What makes us tick
We're recognized as a hub of creativity and innovation
Our vision, values, talent and strategy have been purpose-built to protect the world from cardiovascular disease. To do so requires the deep passion and drive that are inherent to our team at Verve.
Accolades don’t drive us, but a little recognition never hurts
